Buprenorphine-naloxone "microdosing": an alternative induction approach for the treatment of opioid use disorder in the wake of North America's increasingly potent illicit drug market.

Buprenorphine-naloxone "microdosing": an alternative induction approach for the treatment of opioid use disorder in the wake of North America's increasingly potent illicit drug market. CMAJ. 2020 Jan 20;192(3):E73 Authors: Randhawa PA, Brar R, Nolan S PMID: 31959660 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31959660?dopt=Abstract

Source: cmaj - January 19, 2020 Category: General Medicine Authors: Randhawa PA, Brar R, Nolan S Tags: CMAJ Source Type: research

More News: General Medicine | Suboxone